REPLAY: WORLD ORGANOID RESEARCH DAY+ 2024
Poster
8

Enabling Next Generation Functional Characterization of Human Neural Organoids

Authors

S Oldani1; L D'Ignazio1; Z Li1; ME Obien1
1 MaxWell Biosystems, Switzerland

Overview

Human organs, such as the brain, are challenging to study being inaccessible to direct optical observation and experimental manipulation. However, three-dimensional (3D) culture techniques enabled novel study of tissue- or stem cell-derived organoids, spheroids, and organotypic cultures resembling cell type diversity, developmental processes and function of mammalian organs.

Introduction

The ability to measure the electrical activity of a self-organizing in vitro cellular model in real time, live and label-free can provide much needed insights into the complexity of its functional structure. High-density microelectrode arrays (HD-MEAs) provide unprecedented means for non-invasive in-vitro electrophysiological recordings, and can be used to acquire real time measurements from any cell with electrogenic properties, such as iPSC-derived neurons and retina and brain organoids.

Methods

In this study, our HD-MEA platform featuring 26,400 electrodes per well (MaxWell Biosystems AG, Switzerland) was used to capture fast propagating extracellular action potentials in neural organoids at different scales, ranging from network through single-neuron with high spatio-temporal resolution and low noise.

Results

Metrics, such as firing rate, spike amplitude, network burst profile as well as synchronicity, were extrapolated in a parallelized manner. Furthermore, at the subcellular level, we tracked the propagating action potentials across axonal branches to compute and characterize the conduction velocity across multiple neurons within a network.

Conclusion

Our HD-MEA platforms and the extracted parameters highlighted in this study provide a powerful user-friendly approach for identifying and isolating active areas

Agenda

Hosted By

Caterpillar Hill Limited

The organisers of WORLD ORGANOID RESEARCH DAY+ 2024.